from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2454c/-

LFCtreatmentdescriptionclass of inhibitor

-1.920

Amikacinug/mL Amikacintranslation

-2.281

Cap5-10ug/mL Capreomycintranslation

-1.520

Rox10-50 ug/mL Roxithromycintranslation

0.017

SM2-5 ug/mL Streptomycintranslation

-2.469

Tet5-10 ug/mL Tetracyclinetranslation

-2.091

Rif0.2-5ug/mL Rifampicintranscription

-0.785

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.748

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.172

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.702

CPZ10-50 ug/mL Chlorpromazinerespiration

1.051

Clofazimine10-13 ug/mL Clofaziminerespiration

0.489

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.812

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.558

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.627

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.432

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.184

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.721

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.943

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.268

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.176

KCN5-20 ug/mL Potassium cyaniderespiration

0.666

NaN30.2-2 mM Sodium aziderespiration

0.813

Nigericin50 uM Nigericinrespiration

-0.353

TRC10-150 ug/mL Triclosanrespiration

-0.650

TRZ10-25 ug/mL Thioridazinerespiration

-1.663

Valinomycin0.5-10 uM Valinomycinrespiration

0.286

ZnSO42 mM ZnSO4respiration

1.664

menadione6-10 ug/mL Menadionerespiration

0.562

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.151

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.383

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.139

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.363

NRP_1Non-replicating persistence stage 1dosRassociated

0.312

Amp0.2mg/mL AmpicillincellWall

-0.087

Cephalexin20-100 ug/mL CephalexincellWall

0.112

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.612

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.430

EMB10-20 ug/mL EthambutolcellWall

0.193

Eta12-40 ug/mL EthionamidecellWall

-0.382

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.175

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.327

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.177

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.365

BZA0.12 mg/mL BenzamidearomaticAmides

0.206

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.206

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.388

H2O24 mM hydrogen peroxideDNAdamaging

-2.758

Levo10 ug/mL LevofloxacinDNAdamaging

0.288

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.302

Novobiocin10 ug/mL NovobiocinDNAdamaging

-1.680

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.037

UVUV-irradiationDNAdamaging

2.442

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.003

Antimycin12.5-50 ug/mL Antimycin A?

-0.470

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.168

PA_110-50 ug/mL Antitubercular compound PA-1?

0.396

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.480

PA8240.2-2 ug/mL PA-824?

0.763

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.312

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.460

Verapamil50 uM Verapamil?

-0.004

mercaptoethanol2 mM 2-Mercaptoethanol?

0.206

methoxatin10-20 ug/mL Methoxatin?